PETCT (positron emission tomography – computed tomography) is a combination of functional imaging (PET) and anatomical imaging (CT). It is now integral in most cancer patients pathways; altering the staging in approximately a third of patients. It is also used in the evaluation of treatment response, aiding future management decisions. As a result PETCT imaging, in particular FDG PETCT (F18-fluorodeoxyglucose), is increasingly being reviewed and discussed in the multidisciplinary team setting, often by non PETCT specialist radiologists. Knowledge of PETCT incidentalomas and mimics is important. In this article we examine some of these findings in more detail and suggest a systematic method for evaluating FDG avid lesions.

The content on this page is provided by the individuals concerned and does not represent the views or opinions of RAD Magazine.

Stay up to date with
RAD Magazine

Sign up for our newsletter.

We care about your data. Read our privacy policy.